Related Experiment Video
Updated: Dec 6, 2025
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
Neuroendocrine Tumors: Imaging of Treatment and Follow-up
Agata E Migut1, Harmeet Kaur2, Rony Avritscher3
1Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Abstract:
Neuroendocrine neoplasms are a heterogeneous group of tumors arising from cells distributed throughout the body. Local and regional disease is managed with surgical resection; however, treatment of higher-grade neuroendocrine tumors (NETs), unresectable or metastatic disease is complex involving a combination of systemic targeted agents, transarterial embolization, and peptide receptor targeted therapies and is discussed in detail. The most important concept in modern NET workup is that an optimal diagnostic strategy requires combination of both anatomic and functional imaging modalities. NETs often present with unknown primary site of disease, and 68Ga-DOTATATE PET can now diagnose these lesions with great sensitivity.
Insights
Neuroendocrine tumors (NETs) are diverse. Advanced imaging, like 68Ga-DOTATATE PET scans, is crucial for diagnosing NETs, especially those with unknown primary sites.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Neuroendocrine neoplasms (NETs) represent a diverse class of tumors originating from neuroendocrine cells found throughout the body.
- While localized NETs are often treated with surgical resection, managing higher-grade, unresectable, or metastatic disease presents significant complexity.
- Treatment for advanced NETs involves a multifaceted approach, including systemic targeted agents, transarterial embolization, and peptide receptor targeted therapies.
Purpose of the Study:
- To highlight the complexity in managing advanced neuroendocrine tumors (NETs).
- To emphasize the critical role of integrated diagnostic strategies in the workup of NETs.
- To discuss the diagnostic capabilities of modern imaging modalities for NET detection.
Main Methods:
- Review of current treatment paradigms for unresectable and metastatic neuroendocrine tumors.
- Discussion of the importance of combining anatomic and functional imaging for optimal NET diagnosis.
- Evaluation of the diagnostic performance of 68Ga-DOTATATE PET in identifying NET lesions, particularly those with an unknown primary.
Main Results:
- The management of advanced, unresectable, or metastatic NETs requires a combination of systemic therapies, interventional radiology techniques, and targeted radiopharmaceutical treatments.
- An optimal diagnostic strategy for NETs necessitates the integration of both anatomic and functional imaging modalities.
- 68Ga-DOTATATE PET demonstrates high sensitivity in diagnosing NET lesions, proving particularly effective for identifying primary sites of unknown origin.
Conclusions:
- Integrated imaging approaches are fundamental for the accurate diagnosis and staging of neuroendocrine neoplasms.
- 68Ga-DOTATATE PET imaging offers a highly sensitive tool for detecting NETs, significantly aiding in the workup of cases with an unknown primary.
- Multidisciplinary management strategies are essential for addressing the complexities of advanced neuroendocrine tumor disease.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
01:27Imaging Studies IV: Magnetic Resonance Imaging
01:14Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
01:27Imaging Studies III: Computed Tomography